First Anticancer Drug via On-Body Injector

Company Sanofi (EURONEXT: SAN; Nasdaq: SNY) Event Type FDA approval — subcutaneous formulation, ahead of the July 23 PDUFA Modality Anti-CD38 monoclonal antibody, subcutaneous — delivered via CirCLIQ on-body injector (Enable Injections enFuse platform) and manual SC Target CD38 Indication Multiple myeloma — all currently…